Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.

Source:http://linkedlifedata.com/resource/pubmed/id/18927241

Download in:

View as

General Info

PMID
18927241